OMER : Summary for Omeros Corporation - Yahoo Finance

U.S. Markets closed

Omeros Corporation (OMER)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
11.56+0.20 (+1.76%)
At close: 4:00PM EDT
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close11.36
Bid11.00 x 100
Ask11.67 x 200
Day's Range11.30 - 11.74
52 Week Range7.20 - 16.38
Avg. Volume405,390
Market Cap506.58M
PE Ratio (TTM)-7.01
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Omeros: Power in the Pipeline
    Motley Fool2 days ago

    Omeros: Power in the Pipeline

    This tiny biotech could be Alexion's worst nightmare

  • Accesswire5 days ago

    Omeros and Keryx are Potential Beneficiaries of New Administration Deregulation

    NEW YORK, NY / ACCESSWIRE / March 21, 2017 / The current word from market observers is that the biotech sector may have new life breathed into it by a Republican led Congress and the new administration. ...

  • Omeros Corp. :OMER-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017
    Capital Cube5 days ago

    Omeros Corp. :OMER-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017

    Categories: Yahoo Finance Get free summary analysis Omeros Corp. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Omeros Corp. – Genetic Technologies Limited Sponsored ADR, Pfizer Inc., BioTime, Inc., Johnson & Johnson, Akorn, Inc., DURECT Corporation and Pain Therapeutics, Inc. (GENE-US, PFE-US, BTX-US, JNJ-US, AKRX-US, DRRX-US ... Read more (Read more...)